Dialysis Business Plan

It was once performed almost exclusively in hospitals. Together they operate about 3,900 locations nationwide — roughly the same number of Target, Best Buy, and Publix Super Market stores combined. That figure includes not only dialysis itself, but the costs of collateral emergency room visits and hospitalizations.

It was once performed almost exclusively in hospitals. Together they operate about 3,900 locations nationwide — roughly the same number of Target, Best Buy, and Publix Super Market stores combined. That figure includes not only dialysis itself, but the costs of collateral emergency room visits and hospitalizations.

Tags: Famous Business PlansLife Didactic EssayLove Towards Family EssaySuny Albany Application EssayStanford Gsb EssayDissertation Health Occupational Proposal Safety

“Those kind of drugs have been huge,” says Klassen.

“They have had an enormous impact prolonging the lives of patients.” Amgen, the California biotech company that holds the patent on Epogen, has reaped roughly $40 billion in sales since the FDA approved it for use in 1989, making it one of the biggest blockbuster drugs ever.

Both Fresenius and Da Vita grew dramatically starting about 15 years ago as they moved to consolidate the sector.

The market leaders might be even more profitable if not for the litigation surrounding their business practices.

Dialysis also became so expensive that Congress expanded the Medicare program in 1973 to include coverage for any patient who needed it. Renal Data System, 468,000 patients underwent dialysis in 2013.

Best Uk Essay Writers - Dialysis Business Plan

That expansion initially covered some 10,000 patients. That’s a nearly 47-fold increase in 40 years, driven in part by the rise nationwide in diabetes, hypertension, and other chronic conditions.

It is grueling for patients, whose bodies can experience wrenching physiological changes in the course of a typical four-hour session.

“There is clearly a downhill course” for dialysis patients, says David Klassen, MD, the chief medical officer for the United Network of Organ Sharing (UNOS), a nonprofit organization that coordinates U. organ transplant activities, and the former longtime director of the kidney transplant program at the University of Maryland Medical Center in Baltimore.

The pharmaceutical industry also benefits tremendously from dialysis.

Aside from regularly receiving blood thinners, many patients also receive Epogen, a drug that stimulates blood cell production (kidneys perform this when functioning properly).